Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|September 3, 2019
Design of Rhenium Compounds in Targeted Anticancer TherapeuticsPhilippe Collery, Didier Desmaele, Veena Vijaykumar
Investigational New Drugs|January 12, 2019
The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancersPhilippe Collery, Vijay Veena, Adhikesavan Harikrishnan, et al.
Anticancer Research|December 31, 2024
Impact of Rhenium(I)-Diselenoether Compound on Cell Adhesion, Migration, Invasion Capacities, and MMP-2 Release in MDA-MB-231 Breast Cancer CellsPhilippe Collery, Didier Desmaele, Adhikesavan Harikrishnan, et al.
Anticancer Research|October 30, 2016
Negative Impact of Total Body Irradiation on the Antitumor Activity of Rhenium-(I)-diselenoetherPhilippe Collery, Francois Santoni, Ahmed Mohsen, et al.
Anticancer Research|April 3, 2020
A New Model Applied for Evaluating a Rhenium-diselenium Drug: Breast Cancer Cells Stimulated by Cytokines Induced from Polynuclear Cells by LPSVijay Veena, Adhikesavan Harikrishnan, Basavegowda Lakshmi, et al.
Anticancer Research|October 30, 2016
Dose Effect of Rhenium (I)-diselenoether as Anticancer Drug in Resistant Breast Tumor-bearing Mice After Repeated AdministrationsPhilippe Collery, François Santoni, Joseph Ciccolini, et al.
Anticancer Research|February 29, 2024
Effectiveness of Rhenium(I)-diselenoether Low Doses in a Triple-negative Breast Cancer Chicken Embryo ModelPhilippe Collery, Chloe Prunier, Emilien Dosda, et al.
Anti-Cancer Drugs|October 2, 2008
Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanismsLakkireddy Harivardhan Reddy, Humberto Ferreira, Catherine Dubernet, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 20, 2007
A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia typesL Harivardhan Reddy, Catherine Dubernet, Sinda Lepetre Mouelhi, et al.
Plos One|April 25, 2014
Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigationsHafiz Muhammad Ali, Giorgia Urbinati, Hubert Chapuis, et al.
Pageof 3